Ann Arbor, MI, February 06, 2015 --(PR.com
)-- Dr. Robert H. Burke and the staff of the Michigan Center for Cosmetic announce the introduction of microneedling with Platelet Rich Plasma (PRP) the latest innovation in nonsurgical skin rejuvenation.
"In an efforts to provide our patients with the best proven innovations in aesthetic skin care, we choose the Eclipse Micropen and Eclipse PRP systems for our patients. This choice was based on extensive research, finding this to be the state of the art in microneedling and PRP," says Dr. Robert Burke, medical director of the Michigan Center for Cosmetic Surgery.
A single use, sterile treatment tip with 12 micro needles is attached to a micro vibrating handpiece and passed over the areas to be treated at controlled depths depending on the severity of the condition and the goals of treatment. This creates microchannels through the skin, providing a pathway for delivery of optimizing medications and growth factors to the formative cells which ultimately result in improvements in fine to moderate lines, color, texture, and volume of the skin. This can also be used to treat sun damaged skin, acne scars, scars from surgery or injury, and stretchmarks.
Adding your own platelet rich plasma through a process of drawing a small amount of your blood, and placing it in a centrifuge to separate out your own growth factors, then applying to the skin surface microchannels results in even more improvement.
“This is part of our holistic, natural approach to aesthetic skin care. Nothing is more natural for you than your own growth factors concentrated so that they result in more youthful and vibrant skin,” says Dr. Burke.
The Michigan Center for Cosmetic Surgery is committed to providing noninvasive and minimally invasive solutions to those seeking a more youthful appearance. “We strive to provide safe, scientifically based cosmetic surgical patient care,” according to Dr. Burke.
Dr. Burke, is a Clinical Professor at Michigan State University and an Adjunct Clinical Professor at the University of Michigan. He is principal investigator in FDA studies of silicone breast implants for Mentor and Allergan Corporations, and in IRB approved laser research projects with Erconia and Quanta laser corporations.